|
ASPH expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.119000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.320000E-02 |
| Normal-vs-Stage2 |
1.365440E-01 |
| Normal-vs-Stage3 |
2.603600E-02 |
| Normal-vs-Stage4 |
5.787900E-02 |
| Stage1-vs-Stage2 |
6.998600E-01 |
| Stage1-vs-Stage3 |
1.848570E-01 |
| Stage1-vs-Stage4 |
2.566600E-01 |
| Stage2-vs-Stage3 |
4.231800E-01 |
| Stage2-vs-Stage4 |
4.538600E-01 |
| Stage3-vs-Stage4 |
9.539400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.704300E-03 |
| Normal-vs-AfricanAmerican |
7.038400E-01 |
| Normal-vs-Asian |
3.460400E-01 |
| Caucasian-vs-AfricanAmerican |
4.492000E-02 |
| Caucasian-vs-Asian |
5.128000E-01 |
| AfricanAmerican-vs-Asian |
3.858200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.652190E-02 |
| Normal-vs-Female |
1.490040E-02 |
| Male-vs-Female |
9.925800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.603800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.761700E-02 |
| Normal-vs-Age(61-80Yrs) |
4.442000E-03 |
| Normal-vs-Age(81-100Yrs) |
4.703600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.463580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.207900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.361200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.399810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.105400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.353600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.888200E-02 |
| Normal-vs-Grade 2 |
2.184400E-02 |
| Normal-vs-Grade 3 |
1.280220E-01 |
| Normal-vs-Grade 4 |
3.302100E-02 |
| Grade 1-vs-Grade 2 |
4.971600E-01 |
| Grade 1-vs-Grade 3 |
2.972400E-01 |
| Grade 1-vs-Grade 4 |
6.215800E-01 |
| Grade 2-vs-Grade 3 |
2.710400E-01 |
| Grade 2-vs-Grade 4 |
2.694800E-01 |
| Grade 3-vs-Grade 4 |
1.156820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.434200E-02 |
| Normal-vs-ccB subtype |
8.204300E-03 |
| ccA subtype-vs-ccB subtype |
1.459560E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.576150E-02 |
| Normal-vs-N1 |
2.801000E-01 |
| N0-vs-N1 |
6.039600E-01 |
|
|
